Advances in the pharmacotherapy of Heart Failure: type 2 sodium-glucose cotransporter Inhibitors (SGLT2) as a therapeutic option. Research, Society and Development, [S. l.], v. 12, n. 3, p. e12412340502, 2023. DOI: 10.33448/rsd-v12i3.40502. Disponível em: https://rsdjournal.org/rsd/article/view/40502. Acesso em: 6 dec. 2025.